-
Psyched: Novamind Partners With Merck, Atai Expands To Japan, Australia Funds Psychedelics Research
Monday, March 22, 2021 - 9:09am | 997Novamind Strikes Research Deal With Merck Psychedelics company Novamind (PINK: NVMDF) announced a subsidiary has been selected as a research site for a clinical trial of a compound developed by pharma giant Merck (NYSE: MRK). The phase II trial will assess the efficacy and safety of MK-1942,...
-
Field Trip Secures $76M For Psychedelics Clinics, Drug Development
Wednesday, March 17, 2021 - 4:16pm | 307Field Trip Health (OTCQX: FTRPF) announced Wednesday the closing of a CA$95 million ($76.5 million) offering. The raise is one of the largest in the sector’s history, and puts Field Trip’s cash on hand at roughly CA$113.7 million ($91.5 million). Proceeds are expected to be used...
-
The Horizons Psychedelic Stock Index ETF, As Told By Its Fund Manager
Thursday, February 11, 2021 - 11:33am | 1149On January 27, the Horizons Psychedelic Stock Index ETF (NEO:PSYK) became the first exchange traded fund to focus solely on the psychedelics industry. Horizons ETFs CEO Steve Hawkins sat down with Benzinga to discuss the listing, which brought in approximately CA$25 million ($19.4 million) in...
-
Psyched: First Psychedelics ETF Debuts; Hawaii, Florida and Connecticut Eye Psilocybin Legalization; Psyence Goes Public
Sunday, January 31, 2021 - 1:02pm | 1263First Psychedelics ETF Debuts On NEO Exchange Psychedelics’ first exchange traded fund went public last Wednesday. The Horizons Psychedelic Stock Index ETF is now listed on Toronto’s NEO exchange under the symbol ‘PSYK’, and managed by Horizons ETFs Management. PSYK is a...
-
Psyched: NeonMind, Novamind Go Public; MAPS And Field Trip Study MDMA; Psychedelics Center Launches In NYC
Sunday, January 10, 2021 - 9:55am | 1067NeonMind Goes Public Psychedelics biotech company NeonMind debuted on the Canadian Securities Exchange (CSE) Monday under the symbol ‘NEON.’ NeonMind CEO Penny White discussed the highly anticipated — oversubscribed — initial public offering (IPO) on the Jan. 7 edition...
-
Psyched: Canada Allows Psilocybin Use For Healthcare Pros, UK Begins DMT Trials, Cybin To Purchase Adelia
Monday, December 14, 2020 - 11:09am | 892Canada Allows Professionals In Training To Use Psilocybin The Canadian Health Minister Patty Hajdu has allowed 17 healthcare professionals to possess and use psilocybin to conduct professional training in psilocybin-assisted therapy. The decision, announced Tuesday, marks the latest step in Canada...
-
Understanding The Psilocybin Supply Chain: Every Production Method Explained
Wednesday, December 2, 2020 - 9:57am | 1782Psilocybin is known as the active compound in so-called “magic mushrooms”, yet most psilocybin used in clinical trials today is synthesized in laboratories without the use of biological material. As psychedelics-assisted therapy gains momentum, investors need to understand the...
-
Psyched: German Government Funds Psilocybin Study, Field Trip Opens Psilocybin Clinic
Saturday, November 21, 2020 - 11:47am | 793Global Developments in Germany, Canada and Brazil Germany has approved a large phase 2b study on psilocybin for treatment-resistant depression. Dr. Gerhard Gründer, of the Central Institute of Mental Health Mannheim, will lead the study alongside the Department of Psychiatry and...
-
Psyched: Oregon Legalizes Psilocybin, Washington DC Decriminalizes Psychedelics, Cybin And Entheon To Go Public
Saturday, November 7, 2020 - 6:47pm | 794Oregon has become the first state in US history to set up a program that regulates psilocybin, the active psychedelic ingredient in “magic mushrooms.” Measure 109 was approved by 55.8% of voters in a ballot vote on Election Day. The measure creates a state-licensed psilocybin-...
-
Psyched: St. Vincent OKs Psychedelics Program, Delic To Go Public, Field Trip Drug Update
Saturday, October 31, 2020 - 2:41pm | 987Saint Vincent Okays Psychedelic Initiative The Caribbean country of Saint Vincent and the Grenadines has approved an initiative to incentivize psychedelic research and wellness. The small English-speaking island nation, located about 100 miles north of Venezuela’s coast, has passed a...
-
Psyched: Cybin Raises CA$45M, Numinus Harvests Legal Mushrooms, Toadstool Enters Psychedelic Space
Sunday, October 25, 2020 - 9:23am | 976Cybin Raises CA$45 Million and Heads Towards NEO Exchange This week, Toronto-based Cybin Corp. announced the closing of a private offering for CA$45 million ($34.2 million). The raise was completed in connection to Cybin’s previously-announced reverse take-over with Clarmin Explorations (TSXV...
-
Field Trip Health Begins Trading On CSE: Chairman Provides Company Overview
Tuesday, October 6, 2020 - 3:31pm | 1154Common shares of Field Trip Health began trading on the CSE Tuesday morning under the symbol FTRP. The psychedelics company, which has operations in the U.S. and Jamaica, went public through a reverse take-over with Canadian oil and gas explorer Newton Energy Corp. “...
-
Psychedelic-Enhanced Psychotherapy Clinic Opens In Toronto
Wednesday, March 4, 2020 - 2:26pm | 417Field Trip Health, a wholly owned subsidiary of Field Trip Psychedelics, a mental wellness company focused on psychedelics and psychedelic-enhanced psychotherapy, debuted its first medical center in Toronto on Wednesday. The center will be dedicated exclusively to the administration of psychedelic-...